课题基金 / 基金详情

Identification of biomarkers indicative of Respiratory Syncytial Virus (RSV) vaccine-induced immune responses

Identification of biomarkers indicative of Respiratory Syncytial Virus (RSV) vaccine-induced immune responses
鉴定呼吸道合胞病毒 (RSV) 疫苗诱导的免疫反应的生物标志物
批准号：
331492
负责人：
Muralidharan Abenaya
金额：
$1.27万
依托单位：
University of Ottawa
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-12-01 至 2015-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=331492&lang=en
关键词：
Biomarkers Immunopathology Lipidomics Proteomics Respiratory Syncytial Virus Vaccine Development

项目摘要

项目成果

Muralidharan Abenaya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Respiratory Syncytial Virus (RSV) is the most common cause of bronchitis. The infection is associated with 25% of all hospital admissions of lower respiratory tract disease amongst infants younger than one year. It is also increasingly recognized as an i
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the balance between stimulatory and suppressive functions of neutrophils during SARS-CoV-2 infection
  • 批准号：
    440535
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $10.93万
  • 财政年份：
    2020
  • 负责人：
    Muralidharan Abenaya
  • 依托单位：
    University of Nebraska Medical Center
海外基金